openPR Logo
Press release

Autotransfusion Devices Market to Top A Valuation Of USD 419.3 Million by 2032 | LivaNova PLC (U.K.), Medtronic (Ireland), Haematonics Corporation (U.S.

05-22-2023 05:07 AM CET | Health & Medicine

Press release from: Global Insight Services

Autotransfusion Devices Market

Autotransfusion Devices Market

The global autotransfusion devices market was valued at USD 255 million in 2022 and it is anticipated to grow further till USD 419.3 million by 2032, at a CAGR of 5.1% during the forecast period.

Get Access to A Free Sample Copy of Our Latest Report - https://www.globalinsightservices.com/request-sample/GIS10450

To collect and re-infuse the patient's blood, autotransfusion devices are frequently employed. The use of autologous blood transfusions to prevent infections brought on by allogeneic blood transfusions is made possible by these systems, which play a significant part in cell salvage approaches. These tools are used in invasive procedures for the heart, the joints, the nervous system, obstetrics, and gynecology. Systems can be divided into intraoperative systems, post-operative systems, and dual-mode systems based on how usable they are.

Market Trends and Drivers

Some of the major drivers anticipated to propel market expansion during the projected period include an increase in surgical operations, an increase in the number of surgical cases, and an increase in the number of liver or other organ transplant surgeries. Additionally, it is predicted that the market would expand due to the growing older population in the world as well as increased demand for cardiac devices. The rise in blood illnesses, the number of trauma and accident cases, and technological advancements all contribute to the growth of the blood transfusion device.

View Detailed Report Description - https://www.globalinsightservices.com/reports/autotransfusion-devices-market-2/

Major Players in the Global Autotransfusion Devices Market

The key players studied in the report are LivaNova PLC (U.K.), Medtronic (Ireland), Haematonics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), BD (Becton, Dickinson, and Company) (U.S.), Beijing Jingjing Medical Equipment Co., Ltd. (China), and ProCell Surgical Inc. (U.S.) among others.

COVID-19 Impact

The expansion of the autotransfusion devices market was adversely affected by the COVID-19 pandemic epidemic. It demonstrated a significant drop in revenue as a result of fewer surgical procedures being conducted. These tools are primarily utilized during heavy blood loss procedures, like orthopedic and heart surgery.

The need for autologous blood transfusion equipment has decreased along with the decline in surgical procedures. For instance, the COVID-19 pandemic was said to have caused a 48% decrease in the total number of surgical procedures carried out in the United States, according to data published by the American Medical Association. However, the number of surgical procedures rebounded to normal levels once the pandemic limitations were lifted.

Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS10450

Global Autotransfusion Devices Segmentation

By Product

• Autotransfusion Systems
• Consumables & Accessories

By Application

• Cardiovascular Surgeries
• Orthopedic Surgeries
• Neurological Surgeries
• Obstetrics & Gynecological Surgeries
• Others

By End User

• Hospitals
• Specialty Clinics & Others

Buy Now - https://www.globalinsightservices.com/checkout/single_user/GIS10450

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

New Report Published by Global Insight Services : https://www.globalinsightservices.com/reports/hydrogen-projects-database/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autotransfusion Devices Market to Top A Valuation Of USD 419.3 Million by 2032 | LivaNova PLC (U.K.), Medtronic (Ireland), Haematonics Corporation (U.S. here

News-ID: 3061281 • Views:

More Releases from Global Insight Services

Glp-1 Agonist Market To Surge From $53 BN To $264.9 BN By 2034 At 17.5% Cagr. Key Players: Hanmi Pharmaceutical, Zydus Cadila, Oramed Pharmaceuticals.
Glp-1 Agonist Market To Surge From $53 BN To $264.9 BN By 2034 At 17.5% Cagr. Ke …
Market Overview GLP-1 Agonist Market is rapidly evolving as the demand for advanced diabetes and obesity treatments continues to rise globally. These drugs, known as glucagon-like peptide-1 receptor agonists, help improve insulin secretion, reduce glucagon levels, and enhance satiety-making them a powerful solution for type 2 diabetes and weight management. With diabetes and obesity reaching unprecedented levels, the GLP-1 Agonist Market stands at the forefront of therapeutic innovation. Growing patient awareness,
Financial Risk Management Software Market To Grow From $24.5 BN To $47.8 BN By 2034 At 6.9% Cagr. Key Players: Activeviam, Sas Risk Management, Fiserv.
Financial Risk Management Software Market To Grow From $24.5 BN To $47.8 BN By 2 …
Market Overview Financial Risk Management Software Market is evolving rapidly as financial institutions and enterprises navigate increasingly complex global uncertainties. With tightening regulations and growing exposure to market volatility, organizations are turning toward advanced digital solutions that help identify, assess, and mitigate financial risks in real time. The Financial Risk Management Software Market integrates AI, machine learning, predictive analytics, and cloud technologies to enhance credit, liquidity, operational, and market risk insights.
Esg Risk Management Market To Rise From $268.8 MN To $1,032.2 MN By 2034 At 14.4% Cagr. Key Players: Sustainalytics, Reprisk, Arabesque.
Esg Risk Management Market To Rise From $268.8 MN To $1,032.2 MN By 2034 At 14.4 …
Market Overview ESG Risk Management Market is gaining significant momentum as businesses increasingly prioritize sustainability and ethical governance in their operations. Valued at $268.8 million in 2024, the market is projected to surge to $1,032.2 million by 2034, growing at a CAGR of 14.4%. The ESG Risk Management Market encompasses technologies and services designed to identify, monitor, and mitigate environmental, social, and governance risks, ensuring businesses operate responsibly while complying with
Enterprise Firewall Market To Grow From $15 BN (2024) To $40.3 BN (2034) At 10.4% Cagr. Key Players: Sonicwall, Watchguard, Palo Alto Networks.
Enterprise Firewall Market To Grow From $15 BN (2024) To $40.3 BN (2034) At 10.4 …
Market Overview Enterprise Firewall Market is witnessing substantial growth as organizations worldwide prioritize safeguarding their digital infrastructure from sophisticated cyber threats. Valued at $15 billion in 2024, the market is projected to reach $40.3 billion by 2034, expanding at a CAGR of 10.4%. The Enterprise Firewall Market encompasses solutions designed to secure enterprise networks by monitoring, filtering, and blocking unauthorized access while ensuring uninterrupted business operations. With the surge in cyberattacks,

All 5 Releases


More Releases for Autotransfusion

Autotransfusion Devices Market - Revolutionizing blood management: trust our inn …
Newark, New Castle, USA: The "Autotransfusion Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Autotransfusion Devices Market: https://www.growthplusreports.com/report/autotransfusion-devices-market/7856 This latest report researches the industry structure, sales, revenue,
Autotransfusion Services Market Companies to Watch Post-COVID
U.S. Autotransfusion Services Market Size | 2022 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2028 is latest study published by Fortune Business InsightsThe "U.S. autotransfusion services Market Forecast is set to gain impetus from the increasing number of surgical procedures occurring in the country. It is, in turn, expected to surge the need for
Autotransfusion Systems Market Report Up to 2031
Visiongain has published a new report on Autotransfusion Systems Market Report to 2031. Profiles of Leading Autotransfusion Systems Market players, Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Autotransfusion Systems is widely used to provide autologous blood during surgical procedures. In this process autotransfusion systems allows the transfusion of the patient’s blood rather than using the banked allogenic blood. It is incredibly useful during the critical procedures such as
Global Autotransfusion Devices Market - Forecasts to 2026
The findings reviewed by GME stated that the Global Autotransfusion Devices Market will expand at a CAGR value of 5.5% to reach USD 520 million by 2026 from USD 400 million in 2021. The rising cases of chronic diseases across the developing regions, increasing number of surgical procedures, and increasing number of liver or other organ transplant procedures are some of the key factors expected to drive market growth during
Autotransfusion Devices Market: Increasing Use of Autotransfusion Devices in Hos …
Advancements in medical science have led manufacturers to develop various devices and medical equipment, human life betterment being the sole purpose. Such is the case with blood transfusion, where manufacturers have come up with devices that allow efficient and infection free transfusion. Autotransfusion devices are gaining high acceptance owing to benefits such as infection transmission, better transfer of oxygen and absence of isosensitization. Read Report Overview @ https://www.transparencymarketresearch.com/autotransfusion-devices-market.html With increasing occurrence
Autotransfusion Devices Market
https://www.qandqmarketresearch.com/reports/autotransfusion-devices-market-20 This report studies Autotransfusion Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Advancis Surgical Fresenius Kabi Haemonetics LivaNova Medtronic Terumo Corporation Atrium Medical Stryker ... On the basis of product, this report displays the production, revenue,